← Leaderboards
Kiran Datta
Leidos Biomedical Research, Inc.
$292,634,066
Attributed
$292,634,066
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $277.6M · FY2023–24$500M$375M$250M$125M$0
'23
'24
Funding mix
By agency
NIH$292,634,066 · 1
By mechanism
N01$292,634,066 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Lynn Briscoe$495,968,635
- Ethan Dmitrovsky$597,515,186
- Leonard Freedmand$281,097,701
Others in their field
Other Rising Stars on “Coronavirus Vaccine”
- Angee Greer · Ppd Development Lp$82,531,927
- Kevin Saunders · Duke University$18,205,751
- Victoria Coleman · Leidos Biomedical Research, Inc.$7,090,787
- Timothy O'Connor · Rockefeller University$7,019,416
- Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd$6,937,118
- Lauren Carter · University Of Washington$5,637,003
Research focus
Coronavirus VaccineNational Institute Of Allergy And Infectious DiseaseNext GenerationNovel VaccinesPhase I Clinical TrialsPhase Ii Clinical TrialsPhase Ii TrialSeriesStandardization